CA2562018A1 - Bioactive stents for type ii diabetics and methods for use thereof - Google Patents

Bioactive stents for type ii diabetics and methods for use thereof Download PDF

Info

Publication number
CA2562018A1
CA2562018A1 CA002562018A CA2562018A CA2562018A1 CA 2562018 A1 CA2562018 A1 CA 2562018A1 CA 002562018 A CA002562018 A CA 002562018A CA 2562018 A CA2562018 A CA 2562018A CA 2562018 A1 CA2562018 A1 CA 2562018A1
Authority
CA
Canada
Prior art keywords
polymer
stent
bioligand
biodegradable
bioactive agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002562018A
Other languages
English (en)
French (fr)
Inventor
Kenneth W. Carpenter
William G. Turnell
Kristen M. Defife
Kathryn A. Grako
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medivas LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2562018A1 publication Critical patent/CA2562018A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/256—Antibodies, e.g. immunoglobulins, vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A61L2300/608—Coatings having two or more layers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
CA002562018A 2004-04-05 2005-04-04 Bioactive stents for type ii diabetics and methods for use thereof Abandoned CA2562018A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55993704P 2004-04-05 2004-04-05
US60/559,937 2004-04-05
PCT/US2005/011231 WO2005097186A2 (en) 2004-04-05 2005-04-04 Bioactive stents for type ii diabetics and methods for use thereof

Publications (1)

Publication Number Publication Date
CA2562018A1 true CA2562018A1 (en) 2005-10-20

Family

ID=35125623

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002562018A Abandoned CA2562018A1 (en) 2004-04-05 2005-04-04 Bioactive stents for type ii diabetics and methods for use thereof

Country Status (6)

Country Link
EP (1) EP1737379A4 (de)
JP (1) JP2007532185A (de)
CN (1) CN1984620B (de)
AU (1) AU2005231458A1 (de)
CA (1) CA2562018A1 (de)
WO (1) WO2005097186A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160287708A9 (en) * 2000-03-15 2016-10-06 Orbusneich Medical, Inc. Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device
US20060177416A1 (en) 2003-10-14 2006-08-10 Medivas, Llc Polymer particle delivery compositions and methods of use
US20060271168A1 (en) * 2002-10-30 2006-11-30 Klaus Kleine Degradable medical device
EP1699527A1 (de) 2004-01-02 2006-09-13 Advanced Cardiovascular Systems, Inc. Mit lipoprotein hoher dichte beschichtete medizinprodukte
US8163269B2 (en) * 2004-04-05 2012-04-24 Carpenter Kenneth W Bioactive stents for type II diabetics and methods for use thereof
JP5192384B2 (ja) 2005-09-22 2013-05-08 メディバス エルエルシー ビス−（α−アミノ）−ジオール−ジエステル含有ポリ（エステルアミド）およびポリ（エステルウレタン）組成物および使用の方法
CA2623239C (en) 2005-09-22 2016-07-12 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
EP1962894A4 (de) * 2005-12-07 2012-11-14 Medivas Llc Verfahren zum zusammensetzen einer polymer-zusammensetzung zur abgabe eines biologischen mittels
EP2021141A4 (de) * 2006-05-09 2013-07-03 Medivas Llc Biologisch abbaubare wasserlösliche polymere
US7572625B2 (en) * 2006-05-18 2009-08-11 Boston Scientific Scimed, Inc. Medical devices coated with drug carrier macromolecules
US20080172124A1 (en) * 2007-01-11 2008-07-17 Robert Lamar Bjork Multiple drug-eluting coronary artery stent for percutaneous coronary artery intervention
CA2693969A1 (en) * 2007-07-17 2009-01-22 Medivas, Llc Bioabsorbable elastomeric arterial support device and methods of use
US20090074831A1 (en) * 2007-09-18 2009-03-19 Robert Falotico LOCAL VASCULAR DELIVERY OF mTOR INHIBITORS IN COMBINATION WITH PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR STIMULATORS
DE102008027095A1 (de) * 2008-06-06 2009-12-17 Siemens Aktiengesellschaft Interventionsvorrichtung zur Sammlung von biologischem Material und Verfahren zu ihrer Herstellung
CN101879102B (zh) * 2009-05-07 2014-07-09 上海微创医疗器械（集团）有限公司 一种凹槽携载式涂层可降解型药物洗脱支架
CN102596278B (zh) * 2009-10-16 2016-06-29 帝斯曼知识产权资产管理有限公司 包含含有双-(α-氨基-二醇-二酯)的聚酯酰胺的涂层
US9873765B2 (en) 2011-06-23 2018-01-23 Dsm Ip Assets, B.V. Biodegradable polyesteramide copolymers for drug delivery
WO2012175748A1 (en) 2011-06-23 2012-12-27 Dsm Ip Assets B.V. Micro- or nanoparticles comprising a biodegradable polyesteramide copolymer for use in the delivery of bioactive agents
JP2014529997A (ja) 2011-09-23 2014-11-17 ウニヴェルズィテート シュトゥットガルト 免疫グロブリン結合ドメインを使った血清中半減期延長
US9220759B2 (en) 2012-02-23 2015-12-29 Abbott Cardiovascular Systems Inc. Treatment of diabetic patients with a drug eluting stent and adjunctive therapy
US9220584B2 (en) 2012-03-30 2015-12-29 Abbott Cardiovascular Systems Inc. Treatment of diabetic patients with a stent and locally administered adjunctive therapy
EP2934614B1 (de) * 2012-12-20 2021-03-17 DSM IP Assets B.V. Beschichtung aus polyesteramid-copolymeren zur arzneimittelabgabe
CA2969171C (en) 2014-12-18 2023-12-12 Dsm Ip Assets B.V. Drug delivery system for delivery of acid sensitive drugs
EP4069327A1 (de) * 2019-12-04 2022-10-12 Cortronik GmbH Quellfähige polymerhybridfasern für eine hülle einer intraluminalen endoprothese

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0983095B1 (de) * 1997-05-22 2004-09-29 Biomet Deutschland GmbH Peptid-beschichtete implantate und verfahren zu ihrer herstellung
US7052711B2 (en) * 1999-09-02 2006-05-30 Rice University Nitric oxide-producing hydrogel materials
US6379383B1 (en) * 1999-11-19 2002-04-30 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal device exhibiting improved endothelialization and method of manufacture thereof
US20030229393A1 (en) * 2001-03-15 2003-12-11 Kutryk Michael J. B. Medical device with coating that promotes cell adherence and differentiation
WO2001070266A2 (en) * 2000-03-17 2001-09-27 Millennium Pharmaceuticals, Inc. Method of inhibiting stenosis and restenosis with a mixture of antibodies anti cd18 and anti ccr2
JP2001276210A (ja) * 2000-03-28 2001-10-09 Unitika Ltd 抗菌性医療用具及びその製造方法
GB0103668D0 (en) * 2001-02-15 2001-03-28 Biointeractions Ltd Methods and clinical devices for the inhibition or prevention of mammalian cell growth
JP4290985B2 (ja) * 2001-02-16 2009-07-08 アボット ラボラトリーズ バスキュラー エンタープライゼズ リミテッド Ｆｋ５０６を用いたインプラント
WO2003020906A2 (en) * 2001-08-31 2003-03-13 Abmaxis, Inc. Multivalent protein conjugate with multiple ligand-binding domains of receptors
CN1303947C (zh) * 2001-12-13 2007-03-14 华东理工大学 药物洗脱性心血管支架及其制备方法
IL162803A0 (en) * 2002-02-06 2005-11-20 Orbus Medical Technologies Inc Medical device with coating that promotes endothelial cell adherence and differentiation
JP2003320036A (ja) * 2002-05-01 2003-11-11 Terumo Corp ステント
CA2513443A1 (en) * 2003-02-26 2004-09-10 Medivas, Llc Bioactive stents and methods for use thereof
AU2004238270B2 (en) * 2003-05-07 2011-02-03 Advanced Bio Prosthetic Surfaces, Ltd. Metallic implantable grafts and method of making same
ATE361370T1 (de) * 2003-07-17 2007-05-15 Bayerische Julius Maximilians Verwendung von fak verwandten nicht kinase zur herstellung eines medikaments zur inhibierung der stenose und restnose

Also Published As

Publication number Publication date
EP1737379A4 (de) 2011-08-17
AU2005231458A1 (en) 2005-10-20
JP2007532185A (ja) 2007-11-15
WO2005097186A3 (en) 2006-09-14
EP1737379A2 (de) 2007-01-03
WO2005097186A2 (en) 2005-10-20
CN1984620B (zh) 2011-03-30
CN1984620A (zh) 2007-06-20

Similar Documents

Publication Publication Date Title
US8163269B2 (en) Bioactive stents for type II diabetics and methods for use thereof
US20110137406A1 (en) Bioactive stents for type ii diabetics and methods for use thereof
CA2562018A1 (en) Bioactive stents for type ii diabetics and methods for use thereof
CA2566713C (en) Wound healing polymer compositions and methods for use thereof
US20040170685A1 (en) Bioactive stents and methods for use thereof
US20060188486A1 (en) Wound care polymer compositions and methods for use thereof
US20080288057A1 (en) Bioactive Stents For Type II Diabetics and Methods for Use Thereof
US8652504B2 (en) Solid polymer delivery compositions and methods for use thereof
US7794706B2 (en) Bioactive wound dressings and implantable devices and methods of use
US7304122B2 (en) Elastomeric functional biodegradable copolyester amides and copolyester urethanes
JP2008518666A (ja) 生物活性創傷包帯および移植可能な装置ならびに使用法
Huang Engineering RGD-Modified Liposomes for Targeted Drug Delivery to Activated Platelets

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20130404

FZDE Discontinued

Effective date: 20130404